Suppr超能文献

家族性肥厚型心肌病:晚电位及其他预后标志物

Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers.

作者信息

Chaves-Markman Ândrea, Markman Manuel, Santos-Veloso Marcelo Antônio O, Bezerra Lucas S, Sobral Filho Dário C, Markman Filho Brivaldo

机构信息

Cardiology, Rarus - A Rare Disease Service, Recife, BES.

Echocardiography, Agamenon Magalhães Hospital, Recife, BRA.

出版信息

Cureus. 2020 Jan 1;12(1):e6530. doi: 10.7759/cureus.6530.

Abstract

Familial hypertrophic cardiomyopathy is an autosomal dominant genetic disease considered the most common cause of sudden cardiac death in individuals under 35 years old, especially the athletes. This study aimed to investigate the association between the presence of late potentials and a family history of sudden death, syncope, and complex ventricular arrhythmias on patients with hypertrophic cardiomyopathy. A case series study was carried out from March 2001 to December 2002, including 22 patients with hypertrophic cardiomyopathy according to transthoracic echocardiogram criteria. Patients on a cardiac pacemaker, right bundle branch block, cardiac transplant, and under no possibilities to realize the exams were excluded. The results showed that asymmetric septal hypertrophy was the most common type (73%), 63% had a positive familial history of hypertrophic cardiomyopathy, 55% sudden cardiac death, and 23% syncope. Also, complex ventricular arrhythmias were detected in 14% and late potentials in 23% of patients. According to this study, the presence of late potentials was not associated with familial sudden death, syncope, and complex ventricular arrhythmias.

摘要

家族性肥厚型心肌病是一种常染色体显性遗传病,被认为是35岁以下人群,尤其是运动员心脏性猝死的最常见原因。本研究旨在调查肥厚型心肌病患者中晚期电位的存在与猝死、晕厥及复杂性室性心律失常家族史之间的关联。2001年3月至2002年12月开展了一项病例系列研究,根据经胸超声心动图标准纳入22例肥厚型心肌病患者。排除了植入心脏起搏器、右束支传导阻滞、心脏移植患者以及无法进行相关检查的患者。结果显示,不对称性室间隔肥厚是最常见类型(73%),63%患者有肥厚型心肌病家族史阳性,55%有心脏性猝死家族史,23%有晕厥家族史。此外,14%的患者检测到复杂性室性心律失常,23%的患者检测到晚期电位。根据本研究,晚期电位的存在与家族性猝死、晕厥及复杂性室性心律失常无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4124/6996270/306f6600f3da/cureus-0012-00000006530-i01.jpg

相似文献

1
Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers.
Cureus. 2020 Jan 1;12(1):e6530. doi: 10.7759/cureus.6530.
2
A primer on arrhythmias in patients with hypertrophic cardiomyopathy.
Curr Cardiol Rep. 2012 Oct;14(5):552-62. doi: 10.1007/s11886-012-0297-3.
3
[Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
Dtsch Med Wochenschr. 2005 May 6;130(18):1150-4. doi: 10.1055/s-2005-866802.
5
Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy.
J Clin Med. 2023 May 10;12(10):3397. doi: 10.3390/jcm12103397.
6
A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.
Circulation. 2020 Jul 21;142(3):217-229. doi: 10.1161/CIRCULATIONAHA.120.047235. Epub 2020 May 18.
7
Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death.
J Am Coll Cardiol. 1996 Feb;27(2):443-8. doi: 10.1016/0735-1097(95)00485-8.
8
Hypertrophic cardiomyopathy: the importance of arrhythmic events in patients at risk for sudden cardiac death.
Arq Bras Cardiol. 2006 Nov;87(5):649-57. doi: 10.1590/s0066-782x2006001800016.
10
Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Eur J Prev Cardiol. 2017 Jul;24(11):1220-1230. doi: 10.1177/2047487317702519. Epub 2017 May 9.

引用本文的文献

1
Cooperative & competitive binding of anti-myosin tail antibodies revealed by super-resolution microscopy.
Arch Biochem Biophys. 2023 Oct 1;747:109753. doi: 10.1016/j.abb.2023.109753. Epub 2023 Sep 14.

本文引用的文献

1
Risk Stratification in Hypertrophic Cardiomyopathy.
Eur Cardiol. 2015 Jul;10(1):31-36. doi: 10.15420/ecr.2015.10.01.31.
2
Familial Hypertrophic Cardiomyopathy - Identification of cause and risk stratification through exome sequencing.
Gene. 2018 Jun 20;660:151-156. doi: 10.1016/j.gene.2018.03.062. Epub 2018 Mar 21.
3
Genetic cardiomyopathies.
Curr Opin Cardiol. 2018 May;33(3):354-362. doi: 10.1097/HCO.0000000000000512.
6
A One Health Approach to Hypertrophic Cardiomyopathy.
Yale J Biol Med. 2017 Sep 25;90(3):433-448. eCollection 2017 Sep.
7
New Developments in Hypertrophic Cardiomyopathy.
Can J Cardiol. 2017 Oct;33(10):1254-1265. doi: 10.1016/j.cjca.2017.07.007. Epub 2017 Jul 20.
8
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
Circ Res. 2017 Sep 15;121(7):749-770. doi: 10.1161/CIRCRESAHA.117.311059.
9
Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.
Curr Cardiol Rep. 2017 Sep;19(9):81. doi: 10.1007/s11886-017-0897-z.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验